Video Library

Search the Video Library

Filter by Date

Displaying Results 76 - 82 of 82

We are excited to bring you more information for the GRACE Blood Cancer Video Library. For this year's updates to the GRACE Blood Cancer Video Library, Dr. Marco Ruiz, Medical Oncologist in Hematologic Cancers specializing in leukemia, lymphoma, Myelodysplastic syndrome, myelofibrosis, HIV related

We are excited to bring you more information for the GRACE Blood Cancer Video Library. For the GRACE Blood Cancer Video Library, Dr. Marco Ruiz, Medical Oncologist in Hematologic Cancers specializing in leukemia, lymphoma, Myelodysplastic syndrome, myelofibrosis, HIV related malignancies, stem cell

We are excited to bring you more information for the GRACE Blood Cancer Video Library. For the GRACE Blood Cancer Video Library, Dr. Marco Ruiz, Medical Oncologist in Hematologic Cancers specializing in leukemia, lymphoma, Myelodysplastic syndrome, myelofibrosis, HIV related malignancies, stem cell

We are happy to bring you updates to the GRACE Blood Cancer Video Library. For the GRACE Blood Cancer Video Library, Dr. Joshua Brody, Assistant Professor of Medicine, Hematology and Medical Oncology and Director of the Lymphoma Immunotherapy Program at the Icahn School of Medicine at Mount Sinai

We are happy to bring you updates to the GRACE Blood Cancer Video Library. For the GRACE Blood Cancer Video Library, Dr. Joshua Brody, Assistant Professor of Medicine, Hematology and Medical Oncology and Director of the Lymphoma Immunotherapy Program at the Icahn School of Medicine at Mount Sinai

We are happy to bring you updates to the GRACE Blood Cancer Video Library. For the GRACE Blood Cancer Video Library, Dr. Joshua Brody, Assistant Professor of Medicine, Hematology and Medical Oncology and Director of the Lymphoma Immunotherapy Program at the Icahn School of Medicine at Mount Sinai

¿Cuáles son los riesgos y beneficios de ibrutinib y de idelalisib? ¿Cómo manejamos los efectos secundarios de los nuevos inhibidores de la tirosina cinasa?

GRACE sat down with Dr. Marco Ruiz to discuss "What are the risks and benefits of Ibrutinib and Idelalisib?" for our continuing video series with our Spanish speaking faculty on updates in blood cancer treatments.